HOME >> BIOLOGY >> NEWS
Yale ovarian cancer detection technology licensed in China by SurExam

New Haven, Conn. -- Yale University Office of Cooperative Research today announced that it has granted an exclusive license agreement with the Chinese company SurExam Life Science & Technology (Shenzhen) Co. for the commercialization of the university's blood testing technology for epithelial ovarian cancer (EOC).

In the United States, EOC is the fourth most common cancer in women and the leading cause of gynecologic cancer death. EOC affects approximately 25,000 women each year, and more than 16,000 will die from the disease.

SurExam is a Chinese Bio-Pharmaceutical company focusing on the research, development and promotion of products related to early cancer detection. The company's target is to become the leading company in China in the field of diagnostic industry.

The Yale technology for EOC detection is based on analysis of a collection of known serum proteins associated with cancer biology. Each protein marker is assayed using a routine ELISA assay, then the panel of results is scored.

"SurExam is delighted to license the Yale technology for early detection of ovarian cancer in China -- and to help to improve the health of women in our country," said Dr. Jiasen Xu, CEO of SurExam. "As a Chinese scientist trained at Yale, I am honored that SurExam was chosen as the company to develop and commercialize Yale's intellectual property in my motherland. I hope SurExam's work will facilitate future collaboration between Yale and Chinese biotechnology companies."

SurExam is a privately held company funded by private capital. The founders include scientists trained at Yale and other international institutions. The company's scientific team is engaged in cutting-edge cancer research around the world, including universities in USA and China, according to CEO Xu.

Their management team is experienced in biomedical and related ventures and .SurExam has built strategic partnerships with several of the largest hospitals and
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
13-Jun-2006


Page: 1 2

Related biology news :

1. First case of successful ovarian tissue transplantation between two, nonidentical sisters
2. Scientists take next step in understanding potential target for ovarian cancer treatment
3. Common environmental chemicals in diet affect fetal ovarian development
4. Personalized approach to ovarian stimulation achieves high ART pregnancy rates
5. Studies to find better ways to preserve human eggs, ovarian tissue under way
6. PET/CT: The best test for women with ovarian cancer
7. Study pries into ovarian cancers deadly secrets
8. UBC discovery may lead to smart therapies for breast, ovarian cancer
9. Breakthrough vaccine to treat chemo-resistant ovarian cancer
10. Researchers identify ovarian cancer biomarkers
11. National Institutes of Health to map genomic changes of lung, brain and ovarian cancers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 30.37% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... Rosalind™, the first-ever genomics analysis platform specifically designed for life science researchers ... honor of pioneering researcher Rosalind Franklin, who made a major contribution to ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s Medical ... place on 7th and 8th June 2018 in San Francisco, CA. The Summit brings ... well as several distinguished CEOs, board directors and government officials from around the world ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are ... 5.5 million people each year. Especially those living in larger cities are affected by ... in one of the most pollution-affected countries globally - decided to take action. , ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
Breaking Biology Technology:
Cached News: